
Taro Pharmaceutical Industries Ltd. TARO
Annual report 2022
added 07-25-2022
Taro Pharmaceutical Industries Ltd. Total Inventories 2011-2026 | TARO
Annual Total Inventories Taro Pharmaceutical Industries Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 M | 180 M | 153 M | 148 M | 145 M | 141 M | 139 M | 120 M | 118 M | 110 M | 110 M | 107 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 210 M | 107 M | 140 M |
Quarterly Total Inventories Taro Pharmaceutical Industries Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 180 M | - | - | - | 153 M | - | - | - | 148 M | - | - | - | 145 M | - | - | - | 141 M | - | - | - | 139 M | - | - | - | 120 M | - | - | - | 118 M | - | - | - | 110 M | - | - | - | 110 M | 107 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 180 M | 107 M | 134 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MannKind Corporation
MNKD
|
35.3 M | $ 3.56 | 24.48 % | $ 1.09 B | ||
|
Bio-Techne Corporation
TECH
|
189 M | $ 47.41 | -16.36 % | $ 7.47 B | ||
|
United Therapeutics Corporation
UTHR
|
183 M | $ 596.76 | 4.29 % | $ 26.4 B | ||
|
Exelixis
EXEL
|
21.7 M | $ 48.7 | 9.64 % | $ 13.2 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 21.48 | -3.89 % | $ 3.56 B | ||
|
Fortress Biotech
FBIO
|
9.62 M | - | - | $ 71.1 M | ||
|
Esperion Therapeutics
ESPR
|
105 M | $ 3.15 | 1.19 % | $ 655 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.17 | 3.2 % | $ 3.08 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.7 | 3.66 % | $ 452 M |